News | News By Subject | News by Disease News By Date | Search News

Pancreatitis News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
FDA Approves Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (LLY)'s Tradjenta and Jentadueto Labeling to Reflect Pancreatitis Risk     6/21/2013
Isis Pharmaceuticals, Inc. (ISIS)'s apoC-III Shown to Significantly Reduce Triglycerides     4/1/2013
Bristol-Myers Squibb Company (BMY), Merck & Co., Inc. (MRK) Diabetes Drugs Linked to Pancreatitis Risk     2/28/2013
Novartis AG (NVS) Gains FDA Approval for Afinitor(R) as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET     5/6/2011
FDA, European Medicines Evaluation Agency to Re-analyze Repligen Corporation (RGEN)'s Late-Stage Data     5/27/2010
Eurand Granted FDA Approval for ZENPEP(TM)     8/28/2009
Solvay Pharmaceuticals, Inc.'s CREON(R) Delayed-Release Capsules First and Only Pancreatic Enzyme Product to Receive FDA Approval Under New Guidelines     5/1/2009
Eurand (Milan, Italy) (EURX) Granted Priority Review for Zentase NDA     2/21/2008
Novo Nordisk A/S (NVO) Says No Signs Liraglutide Causes Pancreatitis     10/17/2007
Amylin Pharmaceuticals, Inc. (AMLN)'s Byetta Will Add Warning About Pancreas Risk     10/16/2007
Solvay Pharmaceuticals, Inc. Receives Approvable Letter from FDA with Respect to New Drug Application for CREON(R)     8/20/2007
Novozymes A/S And Solvay Pharmaceuticals, Inc. To Collaborate On Digestive Enzymes     11/8/2004

News from Around the Web

Press Releases
Celprogen Introduces 3D Printed Human Pancreas That May Someday Be Utilized In Pancreatic Transplants     12/1/2016
Araim Pharmaeuticals Release: ARA 290 Obtains European Union Orphan Drug Designation For Prevention Of Graft Loss In Pancreatic Islet Transplantation     11/28/2016
AzurRx BioPharma (AZRX) And Mayoly Spindler Announce Initiation Of Phase II Clinical Trial Of MS1819-SD For Exocrine Pancreatic Insufficiency In Chronic Pancreatitis Patients     11/17/2016
Mauna Kea Technologies Release: Cellvizio's Strong Clinical Efficacy In The Prevention Of Certain Pancreatic Cancers Confirmed By Positive Results From Contact Study Presented At UEGW 2016     10/19/2016
Medtronic (MDT) Offers Assurances as Analysts Question Timeline for Artificial Pancreas     8/26/2016
Tandem Diabetes Care And Typezero Technologies Announce License Agreement To Accelerate Development And Commercialization Of Closed-Loop Artificial Pancreas System     7/21/2016
Anthera Provides Clinical Program Updates For Blisibimod And Sollpura     6/29/2016
Celgene (CELG) Announces Presentations Of Investigational Studies In Solid Tumor And Blood Cancers At ASCO 2016     5/19/2016
Antegrin Therapeutics Announces Publication Of Preclinical Data In Pancreatic Fibrosis     4/12/2016
D-Pharm Ltd. Receives Final Report For Phase 2 Clinical Study Of DP-b99 In Acute High-Risk Pancreatitis Patients     7/30/2015
Repligen Corporation (RGEN) Announces Submission of Marketing Authorization Application in EU for SecreFloâ„¢ to Improve Pancreatic Imaging in Patients with Pancreatitis     3/5/2012
Amsterdam Molecular Therapeutics (AMT) (RHP.DE)' Glybera(R) Significantly Reduces the Risk of Pancreatitis in LPLD Patients     6/29/2011
Abbott Japan and Eisai Company, Ltd. (ESALY.PK) Receive Approval to Market the Pancreatic Digestive Enzyme Replacement Drug Lipacreon(R) (pancrelipase) in Japan     4/22/2011
NewLink Genetics to Present Phase 2 Data on HyperAcute(R)-Pancreas Immunotherapy at the American Society of Clinical Oncology Annual Meeting     5/20/2010
Abbott Laboratories (ABT) Receives FDA Approval for CREON(R) to Include Dosing Information for Patients With Chronic Pancreatitis and Pancreatectomy     5/3/2010

//-->